Stay updated on Nivolumab Combo in Relapsed/Refractory HL Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Combo in Relapsed/Refractory HL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Combo in Relapsed/Refractory HL Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0; a maintenance update with no changes to study details or criteria.
    Difference
    0.0%
    Check dated 2026-03-19T06:07:46.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T02:34:04.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Footer updated to Revision: v3.4.2; the funding-lapse notice and the older Revision: v3.4.1 text were removed.
    Difference
    0.3%
    Check dated 2026-02-11T11:48:45.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a system-wide notice about potential data delays due to a lapse in government funding and updated operating status guidance, with references to cc.nih.gov and opm.gov. Updated the page revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.3%
    Check dated 2026-02-04T06:22:28.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Added a glossary display and updated QC-related metadata to show 2025-10-20 Last Update Submitted that Met QC Criteria and Last Update Posted, along with No FEAR Act Data and Revision: v3.4.0. Removed older QC metadata (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data) and the prior Revision: v3.3.4.
    Difference
    0.3%
    Check dated 2026-01-28T04:20:06.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. No substantive changes to study content, layout, or links are evident.
    Difference
    0.0%
    Check dated 2026-01-14T03:22:36.000Z thumbnail image

Stay in the know with updates to Nivolumab Combo in Relapsed/Refractory HL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in Relapsed/Refractory HL Clinical Trial page.